Abid Ali was diagnosed with a heart problem after chest pain during the match



by   |  VIEW 256

Abid Ali was diagnosed with a heart problem after chest pain during the match

Is the vaccine the biggest problem that causes today's athletes to have heart problems or the reason is "excessive" training, certain stimulations, or something else? We still do not have an answer to such a question, but there are certain assumptions and opinions of various experts who are trying to find out what the biggest problem is.

Lately, a large number of athletes have complained of fatigue, heart problems, or problems of some other nature. Of course, such things have always existed, but some believe that the main reason for such problems is vaccines.

Abid Ali, the Pakistan opening batter, is one of those who have experienced a similar fate as a large number of athletes in the last year. Namely, Ali complained about the chest pain midway during the game, which was not a good sign, especially if we take into account the events on the field this year.

Central Punjab is the name of the team in which Abid plays and there was no other option but to leave the field and head to the hospital. PCB has spoken out about its player: "Abid was taken immediately to a cardiac hospital where he was diagnosed as a case of Acute Coronary Syndrome.

He is under the care of Consultant Cardiologist who is liaising with PCB medical team regarding further treatment. He is currently stable." - PCB said, as quoted by cricbuzz

Acure coronary syndromes

Acute coronary syndromes occur due to acute coronary artery obstruction.

The consequences depend on the degree of obstruction and can be classified as unstable pectoral angina, myocardial infarction without ST elevation (NSTEMI), myocardial infarction with ST elevation (STEMI) and can cause sudden death.

The symptoms of these three syndromes are similar and include chest pain with or without dyspnea, nausea, and sweating. The diagnosis is made on the basis of ECG changes and positive or negative biochemical markers. Treatment is based on antiplatelet and anticoagulant drugs, nitrates, β-blockers and in STEMI, on urgent reperfusion of fibrinolytics, percutaneous intervention or sometimes on surgical bridging of coronary arteries.

About 1.5 million myocardial infarctions occur in the United States each year, and the outcome is fatal in 400,000-500,000 cases. Of these, ~ 50% of people die before arriving at the hospital. We hope that there will be fewer such cases in the future, because it is obvious that there are huge heart problems in most athletes, and something must be done about it.